收稿日期: 2024-02-13
网络出版日期: 2024-07-09
基金资助
广州市科技计划项目(2023A03J0784);广州医科大学附属市八医院华英科研基金项目(HY202301B01)
Research on the diagnostic value of pulmonary artery diameter characteristics and combined TNF-α in patients with HIV associated pulmonary hypertension
Received date: 2024-02-13
Online published: 2024-07-09
目的 观察人类免疫缺陷病毒(HIV)感染相关性肺动脉高压(PAH)患者肺动脉管径特征,研究肺动脉管径相关指标联合肿瘤坏死因子-α(TNF-α),筛查诊断HIV相关肺动脉高压的临床价值,为临床提供参考。 方法 选取65例HIV感染患者为研究对象进行回顾性分析,根据超声心动图检查是否合并肺动脉高压分为观察组(23例,存在 PAH)和对照组(42例,无 PAH)。测量两组患者肺动脉内径(PA)、肺动脉直径(dPA)及主动脉直径,并计算dPA与主动脉直径比值(rPA),记录血清TNF-α水平,分析各指标在早期筛查诊断HIV相关肺动脉高压的临床价值。 结果 观察组患者PA、dPA、dPA与主动脉直径比值(rPA)以及TNF-α水平显著高于对照组。Pearson线性相关分析显示,TNF-α与dPA及rPA呈显著正相关。二列相关分析显示,HIV-PAH与PA、dPA、rPA及TNF-α显著相关(P < 0.05)。血清TNF-α与dPA及rPA联合检测诊断HIV-PAH的曲线下面积(AUC)为0.891,敏感度为0.870,特异度为0.881。 结论 肺动脉管径组合指标联合TNF-α能更好地提示HIV-PAH的存在,可以对高风险患者进行早期筛查,对高危人群进行随访或干预,这对改善患者预后具有重要意义。
许庆元 , 袁伟锋 , 陈沐 , 莫晓能 . 人类免疫缺陷病毒相关肺动脉高压患者的肺动脉管径特征及联合肿瘤坏死因子-α的诊断价值[J]. 实用医学杂志, 2024 , 40(13) : 1869 -1874 . DOI: 10.3969/j.issn.1006-5725.2024.13.018
Objective To investigate the characteristics of pulmonary artery diameter in patients with human immunodeficiency virus (HIV) infection-associated pulmonary hypertension (PAH), and to explore the clinical significance of pulmonary artery diameter correlation indices combined with tumor necrosis factor-α (TNF-α) for early screening and diagnosis of HIV-associated pulmonary hypertension, aiming to provide valuable clinical insights. Methods A retrospective analysis was conducted on 65 HIV-infected patients admitted to the Eighth Hospital Affiliated to Guangzhou Medical University between May 2017 and December 2023. Based on echocardiography findings, the patients were categorized into an observation group (23 cases with PAH) and a control group (42 cases without PAH). Measurements of pulmonary artery diameter (PA), distal pulmonary artery diameter (dPA), and aortic diameter were obtained in both groups, and the ratio of dPA to aortic diameter (rPA) was calculated. Additionally, serum TNF-α levels were recorded. The clinical significance of each index in early screening and diagnosis of HIV-related pulmonary hypertension was analyzed. Results The PA, dPA, rPA, and TNF-α levels in the observation group were significantly higher compared to those in the control group. Pearson linear correlation analysis revealed a significant positive correlation between TNF-α and both dPA and rPA. Two-column correlation analysis demonstrated a significant association between HIV-PAH and PA, dPA, rPA, as well as TNF-α (P < 0.05). The combined measurement of serum TNF-α with dPA and rPA exhibited an area under the curve (AUC) of 0.891 for diagnosing HIV-APAH, with a sensitivity of 0.870 and specificity of 0.881. Conclusion The combination of pulmonary artery diameter and TNF-α provides a more accurate indication of the presence of HIV-PAH, enabling early screening, follow-up, or intervention in high-risk patients. This finding holds significant implications for enhancing patient prognosis.
| 1 | HUMBERT M, SITBON O, CHAOUAT A, et al. Pulmonary arterial hypertension in France: results from a national registry [J]. Am J Respir Crit Care Med, 2006, 173(9):1023-1030. doi:10.1164/rccm.200510-1668oc |
| 2 | SITBON O, LASCOUX-COMBE C, DELFRAISSY J F, et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era[J]. Am J Respir Crit Care Med, 2008, 177(1): 108-113. doi:10.1164/rccm.200704-541oc |
| 3 | HENRIQUES-FORSYTHE M, ANNANGI S, FARBER H W. Prevalence and hospital discharge status of human immunodeficiency virus-associated pulmonary arterial hypertension in the United States[J]. Pulm Circ,2015,5(3):506-512. doi:10.1086/682222 |
| 4 | PILLAY B, RAMDIAL P K, NAIDOO D P. HIV-associated large-vessel vasculopathy: a review of the current and emerging clinicopathological spectrum in vascular surgical practice. Cardiovasc J Afr. 2015 Mar-Apr;26(2):70-81. doi:10.5830/cvja-2015-017 |
| 5 | KUMAR A, MAHAJAN A, SALAZAR E A, et al. Impact of human immunodeficiency virus on pulmonary vascular disease[J]. Glob Cardiol Sci Pract,2021,2021(2):e202112. doi:10.21542/gcsp.2021.12 |
| 6 | 卫生部传染病标准专业委员会. 艾滋病和艾滋病病毒感染诊断标准[J]. 中国艾滋病性病, 2012,18(4): 272-275. |
| 7 | 崔立明,韩萍,梁波,等. 16层螺旋CT正常肺动脉管径的测量[J]. 放射学实践, 2006(5):491-493. doi:10.3969/j.issn.1000-0313.2006.05.017 |
| 8 | SIMENAUER A, NOZIK-GRAYCK E, COTA-GOMEZ A. The DNA damage response and HIV-associated pulmonary arterial hypertension[J]. Int J Mol Sci, 2020, 21:3305. doi:10.3390/ijms21093305 |
| 9 | SIMENAUER A, ASSEFA B, RIOS-OCHOA J, et al. Repression of Nrf2/ARE regulated antioxidant genes and dysregulation of the cellular redox environment by the HIV Transactivator of Transcription[J]. Free Radic Biol Med, 2019,141:244-252. doi:10.1016/j.freeradbiomed.2019.06.015 |
| 10 | DEGANO B, GUILLAUME M, SAVALE L,et al. HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era[J]. AIDS, 2010,24(1):67-75. doi:10.1097/qad.0b013e328331c65e |
| 11 | ROHM I, GRüN K, MüLLER L M, et al. Cellular inflammation in pulmonary hypertension: Detailed analysis of lung and right ventricular tissue, circulating immune cells and effects of a dual endothelin receptor antagonist[J]. Clin Hemorheol Microcirc,2019,73(4):497-522. doi:10.3233/ch-180529 |
| 12 | CLAYTOR J D, VIRAMONTES O, CONNER S,et al. TNF-α inhibition in the setting of undiagnosed HIV infection:a call for enhanced Screening guidelines [J]. AIDS, 2021,35(13):2163-2168. doi:10.1097/qad.0000000000002985 |
| 13 | 陆宇红,杨崎恩,孙皆齐,等. TNF-α基因多态性与HIV感染患者抗病毒治疗后CD4+T细胞水平的关联性[J]. 中华医院感染学杂志, 2021,31(12):1875-1880. |
| 14 | 彭秀娟,马永能,刘国雄,等. HIV感染者CD4+ T细胞数与IL-10、TNF-α表达水平的相关性[J]. 国际检验医学杂志, 2016,37(8):1081-1082+1085. |
| 15 | SCHNEIDER M, RAN H, PISTRITTO A M, et al. Pulmonary artery to ascending aorta ratio by echocardiography: A strong predictor for presence and severity of pulmonary hypertension[J]. PLoS One, 2020,15(7):e0235716. doi:10.1371/journal.pone.0235716 |
| 16 | JOHNS C S, RAJARAM S, CAPENER D A, et al. Non-invasive methods for estimating mPAP in COPD using cardiovascular magnetic resonance imaging[J]. Eur Radiol, 2018,28(4):1438-1448. doi:10.1007/s00330-017-5143-y |
| 17 | SHIN S, KING C S, BROWN A W, et al. Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease[J]. Respir Med,2014,108(11):1626-1632. doi:10.1016/j.rmed.2014.08.009 |
| 18 | GALIè N, HUMBERT M, VACHIERY J L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)[J]. Eur Heart J, 2016,37(1):67-119. doi:10.1093/eurheartj/ehv317 |
| 19 | 中华医学会呼吸病学分会肺栓塞与肺血管病学组. 中国肺动脉高压诊断与治疗指南(2021 版)[J]. 中华医学杂志, 2021,101 (1):11-51. |
| 20 | LICHTBLAU M, SAXER S, FURIAN M, et al. Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250 m[J]. Eur Respir J,2020,56(2):1902474. doi:10.1183/13993003.02474-2019 |
| 21 | 吴赤球,林海平,余丹,等. 三种超声心动图经验公式评估高原某部官兵肺动脉压的比较[J]. 武警医学, 2023,34(1):1-4+9. doi:10.3969/j.issn.1004-3594.2023.01.001 |
| 22 | 周伟勇,吴升. CT测定肺动脉和主动脉比值作为特发性肺纤维化患者肺动脉高压诊断和预后指标的研究[J]. 现代医用影像学, 2022,31(9):1656-1658. |
/
| 〈 |
|
〉 |